Handok

Handok Dividend per Share

The Dividend per Share of Handok (002390.KS) as of Nov 16, 2026 is 200.00 KRW. In the previous year, Dividend per Share was 300.00 KRW — a change of -33.33% (lower).

Dividend per Share

200.00KRW

YoY

-33.33%

Last updated:

Dividend per Share of Handok is 2025 200.00 KRW. Dividend per Share of Handok was 2024 300.00 KRW. It decreases by -33.33% lower compared to the previous year.

At today's price the dividend yield works out to roughly 2.43%.

The Handok Dividend per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Dividend per Share
Date
Dividend per Share
Jan 1, 2025
200.00 KRW
Jan 1, 2026 (e)
200.00 KRW
Jan 1, 2027 (e)
200.00 KRW
Jan 1, 2028 (e)
200.00 KRW
Jan 1, 2029 (e)
200.00 KRW
Jan 1, 2030 (e)
200.00 KRW
Jan 1, 2031 (e)
200.00 KRW
Jan 1, 2032 (e)
200.00 KRW
The Handok Dividend per Share history
YEARDividend per ShareYoY
est200.00KRW0.00%
est200.00KRW0.00%
est200.00KRW0.00%
est200.00KRW0.00%
est200.00KRW0.00%
est200.00KRW0.00%
est200.00KRW0.00%
200.00KRW-33.33%
300.00KRW0.00%
300.00KRW-25.00%
400.00KRW+14.29%
350.00KRW+16.67%
300.00KRW+9.09%
275.00KRW-38.89%
450.00KRW+69.81%
265.00KRW+112.00%
125.00KRW+25.00%
100.00KRW-33.33%
150.00KRW-24.19%
197.86KRW+33.33%
148.40KRW-62.50%
395.72KRW-24.53%
524.33KRW+13.98%
460.03KRW+190.63%
158.29KRW-68.00%
494.65KRW0.00%
494.65KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Handok Stock analysis

What does Handok do? Handok, Inc. generates revenue through the manufacture and sale of pharmaceutical products including Amaryl for diabetes, Tritace for hypertension and cardiovascular diseases, Teveten and Triapin for hypertension, Munobal for hypertension and stenocardia, Ketas for cerebral circulation issues, and Lasix for hypertension and edema. The company also sells over-the-counter pharmaceuticals, healthcare products, medical devices, diagnostic reagents, and vaccines. Additionally, Handok, Inc. earns income from real estate rental services. Its products target healthcare providers, hospitals, and pharmacies as key buyers within the pharmaceutical and healthcare sectors. The firm's product portfolio includes branded medications such as Amaryl, Tritace, Teveten, Triapin, Munobal, Ketas, and Lasix, which are distributed to medical professionals and retail pharmacies. Over-the-counter products and healthcare items are sold directly to consumers through retail channels. Medical devices and diagnostic reagents are supplied to healthcare facilities and laboratories. Vaccines are distributed to public health institutions and clinics. Handok, Inc. serves multiple market segments including diabetes management, cardiovascular care, hypertension treatment, and neurological health through its diverse product range. The company's real estate rental business supports its financial operations by providing steady income streams from leased properties. Key buyers include healthcare providers, pharmacies, hospitals, and public health institutions that purchase its branded pharmaceuticals and medical solutions. Handok is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Handok stock

Dividend per Share of Handok is 200.00 KRW in 2025.

Dividend per Share of Handok changed from 300.00 KRW to 200.00 KRW, representing a -33.33% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Dividend per Share Handok since 2006 – with annual values, charts, and detailed analysis.

Dividend per share is the total dividend payment divided by shares outstanding. It shows how much cash each share receives in dividends.

Dividend per Share's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend per Share's Handok historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Handok

All Key Metrics — Handok